Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

164.61 -0.93 (-0.56%)
Official Closing Price Updated: 4:10 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,867,729
Open 166.03
Bid (Size) 164.21 (11)
Ask (Size) 164.60 (1)
Prev. Close 165.54
Today's Range 163.89 - 166.30
52wk Range 155.72 - 186.69
Shares Outstanding 2,628,679,824
Dividend Yield 2.45%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
3 Dow Stocks That Make for Screaming Buys in February
Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight. 
Via The Motley Fool
Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference
From Johnson & Johnson
Via Business Wire

Performance

YTD
-7.62%
-7.62%
1 Month
-7.62%
-7.62%
3 Month
-3.58%
-3.58%
6 Month
-4.18%
-4.18%
1 Year
-4.72%
-4.72%

More News

Read More
Liposome Drug Delivery Market 2023 in-Depth Analysis, Growth, Size, Future Prospect, Regional Development and Global Outlook 2029
Via SBWire
Exposures COVID-19
Johnson & Johnson's Upcoming Lung Cancer Data Could Offer Another Blockbuster Opportunity, Says Analyst
Via Benzinga
3 Defensive Stocks to Buy If You Think the Market Is Headed Lower
Via InvestorPlace
Why Johnson & Johnson Stock Slipped by Nearly 4% on Monday
Via The Motley Fool
Why Is Johnson & Johnson (JNJ) Stock Down Today?
Via InvestorPlace
Looking for a Reliable Dividend Payer? Consider Buying This Blue-Chip Stock
Via The Motley Fool
3 Dividend Stocks to Buy in 2023 for a Lifetime of Passive Income
Via The Motley Fool
Is Johnson & Johnson Stock Worth Buying on the Dip?
Via The Motley Fool
This Low-Risk ETF Can Turn $39,000 Into $1 Million in 25 Years
Via The Motley Fool
Rancho Biosciences Welcomes BenevolentAI as New Member to Its Single Cell Data Science Consortium
Via Newswire.com
How Do Lawsuits Affect Johnson & Johnson's Stock Price?
Via MarketBeat
Topics Bankruptcy Lawsuit
Exposures Financial Legal
3 Stocks You Can Confidently Buy in a Market Downturn
Via The Motley Fool
3 Warren Buffett Stocks to Buy Hand Over Fist in February
Via The Motley Fool
Earnings Roundup: Tesla, Intel, Chevron, and More
Via The Motley Fool
The 7 Best Climate Change Stocks to Buy for 2023
Via InvestorPlace
Sony Scales Back PlayStation VR2 Output, Sam Bankman-Fried Attempted To Regain Control Of FTX, White House Plans To End COVID-19 Emergency: Today's Top Stories
Via Benzinga
US Court Rejects Johnson & Johnson's Controversial Ploy To Evade Talc Cancer Lawsuits
Via Benzinga
Is Visa Stock a Buy?
Via The Motley Fool
These 2 Stocks Led the Dow Lower Monday
Via The Motley Fool
J&J Dives After Court Denies Bankruptcy For Litigation-Hamstrung Baby Powder Division
Via Investor's Business Daily
Osteotomy Plates Market Share with Top Countries Data, Size, Global Industry Challenges, Business Overview and Forecast Research Study 2028
Via SBWire
Topics Supply Chain
Exposures Supply Chain
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
Via Benzinga
3 Dividend Kings to Buy Hand Over Fist in 2023
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.